Bunge Global SA (BG) Market Cap & Valuation Ratios
Bunge Global SA (BG) has a market cap of $19.8B, a trailing P/E of 20.0 and a price-to-sales ratio of 0.2, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BGBunge Global SAFollow BG — free
—
Price chart with a free account
- Market cap
- 19.8B
- P/E TTM
- 20.0
- Dividend yield
- 2.7%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Peers
farm products · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| BG | 20 | 20.0 | 0.4 | 11.1 | -3.6% | +81% | 2% | 7% |
| ADM | 39 | 22.0 | 0.6 | 11.7 | 4.3% | -0.8% | 3% | 7% |
| TSN | 20 | 35.0 | 0.5 | 10.3 | 5.8% | +3% | 2% | 4% |
| CALM | 2.9 | 51.3 | 0.9 | 14.7 | -1.1% | -43% | 0.7% | 0.7% |
| DMC | 1.4 | 42.2 | 0.4 | 11.9 | 7.0% | -0.2% | 2% | 2% |
| DOLE | 1.3 | 21.7 | 0.2 | 7.3 | 6.6% | +8% | 2% | 4% |
| VITL | 0.4 | — | 0.5 | 26.7 | — | +16% | 0.0% | 0.1% |
| AFRI | 0.3 | — | 2.6 | 272.2 | -0.1% | -36% | -2% | -3% |
| VFF | 0.3 | 15.1 | 1.2 | 5.3 | 12.7% | +15% | 16% | 9% |
| ALCO | 0.3 | — | 17.9 | — | -1.3% | -61% | -463% | -151% |
| LMNR | 0.2 | — | 2.3 | — | — | -20% | -36% | -20% |
| Median of these 10 | 28.5 | 0.7 | 11.8 | 5.1% | -0.5% | 1% | 1% |
P/E 20.0 vs. a peer median of 28.5; EV/Sales 0.4 vs. 0.7. BG's own P/E sits at the 82nd percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesVITL and AFRI and ALCO and LMNR have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Bunge Global SA — questions
- What is Bunge Global SA's market cap?
- $19.8B.
- What is Bunge Global SA's P/E ratio?
- 20.0 on trailing twelve-month earnings to 2026-06-30.
- What is Bunge Global SA's price-to-sales ratio?
- 0.2.
Every figure on this page comes from Bunge Global SA's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.